Effect of subacute fatigue on the central nervous system
Not Applicable
- Conditions
- Healthy
- Registration Number
- JPRN-UMIN000018558
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Participants with past or current history of serious medical illness and/or brain organic disease, who take central nervous system acting drugs, who are contradicted to the use of MRI, or who are judged as not suitable for participation in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MEG
- Secondary Outcome Measures
Name Time Method Questionnaires
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link subacute fatigue to central nervous system dysfunction in healthy individuals?
How does subacute fatigue impact neuroinflammatory markers like cytokines or glial activation in CNS studies?
Which biomarkers (e.g., fMRI, EEG, or neurochemical profiles) correlate with subacute fatigue progression in clinical research?
What adverse events are associated with subacute fatigue interventions in CNS studies, and how are they managed?
How do pharmacological agents targeting CNS fatigue (e.g., modafinil, amphetamines) compare to non-pharmacological approaches in clinical trials?